Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 18 | 2025 | 1020 | 2.390 |
Why?
|
| Heart Failure | 19 | 2025 | 2332 | 1.840 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2025 | 161 | 1.070 |
Why?
|
| Shock, Cardiogenic | 3 | 2025 | 176 | 1.010 |
Why?
|
| Vascular Resistance | 4 | 2025 | 182 | 0.860 |
Why?
|
| Cardiac Rehabilitation | 1 | 2023 | 29 | 0.760 |
Why?
|
| Self Care | 1 | 2023 | 231 | 0.690 |
Why?
|
| Myocarditis | 1 | 2022 | 122 | 0.670 |
Why?
|
| Kidney Failure, Chronic | 2 | 2025 | 934 | 0.610 |
Why?
|
| Renal Dialysis | 3 | 2025 | 951 | 0.600 |
Why?
|
| Acute Coronary Syndrome | 1 | 2022 | 235 | 0.580 |
Why?
|
| Patient Care Team | 1 | 2023 | 562 | 0.570 |
Why?
|
| Transducers, Pressure | 1 | 2018 | 10 | 0.560 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 4 | 0.560 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2022 | 299 | 0.540 |
Why?
|
| Heart, Artificial | 1 | 2018 | 46 | 0.530 |
Why?
|
| Heart Transplantation | 4 | 2024 | 800 | 0.510 |
Why?
|
| Drug Overdose | 1 | 2017 | 73 | 0.480 |
Why?
|
| Metoprolol | 2 | 2025 | 21 | 0.460 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 155 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2017 | 482 | 0.380 |
Why?
|
| Electrocardiography | 1 | 2017 | 970 | 0.340 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 362 | 0.320 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2023 | 688 | 0.320 |
Why?
|
| Acute Kidney Injury | 3 | 2025 | 705 | 0.300 |
Why?
|
| Ventricular Function, Left | 3 | 2024 | 549 | 0.270 |
Why?
|
| Pulmonary Artery | 2 | 2024 | 434 | 0.270 |
Why?
|
| Humans | 31 | 2025 | 131163 | 0.260 |
Why?
|
| Treatment Outcome | 11 | 2025 | 12936 | 0.230 |
Why?
|
| Prosthesis Implantation | 2 | 2024 | 152 | 0.220 |
Why?
|
| Health Status | 1 | 2025 | 378 | 0.200 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 222 | 0.200 |
Why?
|
| Cancer Care Facilities | 1 | 2022 | 32 | 0.190 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 178 | 0.180 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2022 | 42 | 0.180 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2023 | 105 | 0.180 |
Why?
|
| Retrospective Studies | 15 | 2024 | 17753 | 0.170 |
Why?
|
| Quality of Life | 4 | 2025 | 2082 | 0.170 |
Why?
|
| Hypertension, Pulmonary | 2 | 2023 | 457 | 0.170 |
Why?
|
| Middle Aged | 14 | 2025 | 28601 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2023 | 325 | 0.160 |
Why?
|
| Rivaroxaban | 1 | 2020 | 49 | 0.150 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 60 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2020 | 70 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2023 | 687 | 0.150 |
Why?
|
| Exercise Tolerance | 2 | 2025 | 91 | 0.150 |
Why?
|
| Palliative Care | 1 | 2023 | 443 | 0.150 |
Why?
|
| Pyridones | 1 | 2020 | 140 | 0.140 |
Why?
|
| Cardiology | 1 | 2023 | 514 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 499 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2020 | 349 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 638 | 0.130 |
Why?
|
| Telemedicine | 1 | 2023 | 526 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 146 | 0.120 |
Why?
|
| Time Factors | 4 | 2024 | 6196 | 0.120 |
Why?
|
| Male | 14 | 2025 | 64957 | 0.120 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 97 | 0.120 |
Why?
|
| Reoperation | 1 | 2020 | 818 | 0.120 |
Why?
|
| Mortality | 1 | 2018 | 264 | 0.120 |
Why?
|
| Double-Blind Method | 2 | 2025 | 1626 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 3061 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 514 | 0.110 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 79 | 0.110 |
Why?
|
| Aged | 9 | 2025 | 21025 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 294 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2018 | 810 | 0.100 |
Why?
|
| Exercise Test | 1 | 2015 | 239 | 0.100 |
Why?
|
| Abscess | 1 | 2015 | 135 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 682 | 0.100 |
Why?
|
| Adult | 7 | 2025 | 31282 | 0.100 |
Why?
|
| Drainage | 1 | 2015 | 250 | 0.100 |
Why?
|
| Radiology | 1 | 2015 | 122 | 0.100 |
Why?
|
| Acute Disease | 1 | 2017 | 1153 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 5196 | 0.100 |
Why?
|
| Endoscopy | 1 | 2015 | 270 | 0.100 |
Why?
|
| Respiratory System Agents | 1 | 2023 | 3 | 0.100 |
Why?
|
| Hospitalization | 2 | 2019 | 1950 | 0.100 |
Why?
|
| Walk Test | 1 | 2023 | 25 | 0.100 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 49 | 0.100 |
Why?
|
| Female | 13 | 2025 | 70963 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2023 | 136 | 0.090 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2013 | 133 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 214 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 216 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2023 | 88 | 0.090 |
Why?
|
| Risk Factors | 4 | 2024 | 11074 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2013 | 449 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1064 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1168 | 0.080 |
Why?
|
| Prognosis | 2 | 2019 | 4886 | 0.080 |
Why?
|
| Stroke Volume | 2 | 2025 | 541 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 1889 | 0.080 |
Why?
|
| Young Adult | 3 | 2020 | 10103 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2020 | 3147 | 0.070 |
Why?
|
| Heart | 1 | 2013 | 650 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1295 | 0.070 |
Why?
|
| Survival Rate | 3 | 2019 | 2114 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 738 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 889 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2017 | 6459 | 0.060 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2025 | 12 | 0.060 |
Why?
|
| Incidence | 3 | 2019 | 3360 | 0.060 |
Why?
|
| United States | 5 | 2019 | 12072 | 0.050 |
Why?
|
| Registries | 2 | 2021 | 1634 | 0.050 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 77 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 294 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2023 | 212 | 0.040 |
Why?
|
| Prealbumin | 1 | 2020 | 27 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 51 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1356 | 0.040 |
Why?
|
| Echocardiography | 1 | 2025 | 1125 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2020 | 229 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 1240 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2020 | 93 | 0.040 |
Why?
|
| Warfarin | 1 | 2020 | 121 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 166 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 274 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2018 | 122 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2019 | 188 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2022 | 605 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 314 | 0.030 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 172 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 712 | 0.030 |
Why?
|
| Equipment Design | 1 | 2018 | 512 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 558 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3711 | 0.030 |
Why?
|
| Medicare | 1 | 2018 | 442 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2595 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 1680 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 558 | 0.020 |
Why?
|
| Stroke | 1 | 2020 | 1061 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 20987 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3385 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3436 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3763 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6797 | 0.020 |
Why?
|
| Child | 1 | 2022 | 26341 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 33912 | 0.010 |
Why?
|